KA
ABBV icon

Kozak & Associates’s AbbVie ABBV Stock Holding History

Kozak & Associates’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Buy
4,766
+11
+0.2% +$2.37K 0.21% 29
2026
Q1 		$982K Sell
4,755
-215
-4% -$47.7K 0.19% 26
2025
Q4 		$1.09M Buy
4,970
+96
+2% +$21.9K 0.21% 25
2025
Q3 		$1.14M Buy
4,874
+25
+0.5% +$5.09K 0.22% 26
2025
Q2 		$924K Buy
4,849
+3,015
+164% +$560K 0.19% 26
2025
Q1 		$328K Buy
1,834
+113
+7% +$22K 0.08% 52
2024
Q4 		$312K Buy
1,721
+39
+2% +$7.17K 0.07% 55
2024
Q3 		$320K Buy
1,682
+211
+14% +$39.4K 0.08% 60
2024
Q2 		$241K Hold
1,471
– – 0.06% 70
2024
Q1 		$242K Sell
1,471
-42
-3% -$7.24K 0.07% 72
2023
Q4 		$244K Sell
1,513
-186
-11% -$27.1K 0.08% 69
2023
Q3 		$252K Buy
1,699
+10
+0.6% +$1.47K 0.09% 70
2023
Q2 		$228K Sell
1,689
-63
-4% -$9.24K 0.09% 77
2023
Q1 		$279K Buy
1,752
+11
+0.6% +$1.68K 0.13% 74
2022
Q4 		$281K Buy
1,741
+10
+0.6% +$1.53K 0.14% 67
2022
Q3 		$245K Buy
1,731
+11
+0.6% +$1.58K 0.15% 67
2022
Q2 		$263K Buy
1,720
+10
+0.6% +$1.53K 0.18% 58
2022
Q1 		$255K Hold
1,710
– – 0.16% 65
2021
Q4 		$255K Buy
1,710
+23
+1% +$2.72K 0.16% 65
2021
Q3 		$197K Buy
+1,687
New +$193K 0.12% 79

Other funds holding ABBV

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Kozak & Associates's ABBV Position: Q2 2026 in Review

Kozak & Associates increased its AbbVie (ABBV) stake by 0.23% in Q2 2026, buying an estimated $2.37K and bringing the position to 4,766 shares worth $1.2M. The position accounts for 0.21% of the portfolio, ranked #29.

Kozak & Associates first reported a position in ABBV in Q3 2021 and has held it in 20 quarters since. 1,291 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Kozak & Associates held 4,766 shares of AbbVie worth $1.2M as of Q2 2026.
  • Kozak & Associates bought 11 AbbVie shares in Q2 2026, an estimated $2.37K.
  • AbbVie made up 0.21% of Kozak & Associates's portfolio in Q2 2026, its #29 holding.
  • Kozak & Associates first reported a position in AbbVie in Q3 2021 and has held it in 20 quarters since.
  • 1,291 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Kozak & Associates's 13F filing for Q2 2026, filed 2 Jul 2026.